Toward reducing immunogenicity of enzyme replacement therapy: altering the specificity of human β-glucuronidase to compensate for α-iduronidase deficiency

Protein Engineering, Design & Selection : PEDS
Huai-Yao ChuangSteve R Roffler

Abstract

Enzyme replacement therapy (ERT) is an effective treatment for many patients with lysosomal storage disorders caused by deficiency in enzymes involved in cell metabolism. However, immune responses that develop against the administered enzyme in some patients can hinder therapeutic efficacy and cause serious side effects. Here we investigated the feasibility of a general approach to decrease ERT immunogenicity by altering the specificity of a normal endogenous enzyme to compensate for a defective enzyme. We sought to identify human β-glucuronidase variants that display α-iduronidase activity, which is defective in mucopolysaccharidosis (MPS) type I patients. A human β-glucuronidase library was screened by the Enzyme Cleavable Surface-Tethered All-purpose Screen sYstem to isolate variants that exhibited 100-290-fold greater activity against the α-iduronidase substrate 4-methylumbelliferyl α-l-iduronide and 7900-24 500-fold enzymatic specificity shift when compared with wild-type β-glucuronidase. In vitro treatment of MPS I cells with the β-glucuronidase variants significantly restored lysosome appearance similar to treatment with α-iduronidase. Our study suggests that β-glucuronidase variants can be isolated to display α-iduronid...Continue Reading

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·M R NatowiczW S Sly
Jan 1, 1976·Journal of Immunological Methods·J W Goding
Jan 1, 1966·Annual Review of Physiology·C De Duve, R Wattiaux
Jan 17, 2004·Biotechnology and Applied Biochemistry·Chia-Hung WuSteve R Roffler
Apr 8, 2004·The Journal of Biological Chemistry·Melissa L Geddie, Ichiro Matsumura
Oct 2, 2004·Kidney International·Gabor E LinthorstJohannes M F G Aerts
Feb 11, 2005·Human Gene Therapy·Carmela Di DomenicoPaola Di Natale
May 3, 2005·Molecular Genetics and Metabolism·Brian P RempelStephen G Withers
Jun 10, 2006·Journal of Inherited Metabolic Disease·Janice M Fletcher
Oct 10, 2007·American Journal of Human Genetics·Baodong SunDwight D Koeberl
Jul 10, 2008·The Journal of Gene Medicine·Ramin Sedaghat HeratiKatherine P Ponder
Sep 2, 2008·Biological & Pharmaceutical Bulletin·Takahiro TsukimuraHitoshi Sakuraba
Oct 23, 2008·Lancet·Yuri A Zarate, Robert J Hopkin
Apr 2, 2009·Pediatrics·Orna Staretz-ChachamEllen Sidransky
Nov 17, 2009·The Journal of Pediatrics·Diego G PeroniAttilio L Boner
Apr 13, 2010·BMC Bioinformatics·Andrew S ParkerChris Bailey-Kellogg
Jan 7, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jason R CantorGeorge Georgiou
May 23, 2012·Molecular Genetics and Metabolism·Trusha T PatelPriya S Kishnani
Jun 14, 2012·Protein Engineering, Design & Selection : PEDS·Cheng-Pao ChenSteve R Roffler
Aug 9, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Toya OhashiHiroshi Kobayashi
Aug 18, 2012·Protein Engineering, Design & Selection : PEDS·Daniel C OsipovitchKarl E Griswold
Jan 10, 2013·Journal of Computational Chemistry·Yoonjoo ChoiChris Bailey-Kellogg
Feb 6, 2013·Proceedings of the National Academy of Sciences of the United States of America·Daren WangDao Pan
Aug 21, 2013·Proceedings of the National Academy of Sciences of the United States of America·Nobuo MaitaHitoshi Sakuraba
Aug 29, 2013·Journal of Biomolecular Screening·Miao XuWei Zheng
Jun 2, 2014·Cellular and Molecular Life Sciences : CMLS·Regina S SalvatKarl E Griswold
Aug 5, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Salim S El-AmouriDao Pan
Oct 15, 2014·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Luis Felipe EnsinaMariana Castells

❮ Previous
Next ❯

Citations

Dec 30, 2017·Bioconjugate Chemistry·Shaheen A FarhadiGregory A Hudalla

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.